Key result
EP-related cardiac tamponade was associated with a higher 5-year risk of death, MI, TIA/stroke, or heart failure hospitalization compared to matched controls (20.0% vs 10.6%; HR 2.53; P=0.021).
Why the study?
Iatrogenic cardiac tamponade is a rare but dreaded complication of invasive electrophysiology procedures, but its long-term impact on clinical outcomes is unknown.
Does EP-related cardiac tamponade increase the risk of long-term death or serious cardiovascular events in patients undergoing invasive electrophysiology procedures?
Cohort (n=240)
No
Does EP-related cardiac tamponade increase the risk of long-term death or serious cardiovascular events in patients undergoing invasive electrophysiology procedures?
EP-related cardiac tamponade is associated with an increased risk of early TIA/stroke and pericarditis, but long-term mortality and other serious cardiovascular events are not significantly increased.
May warrant closer long-term surveillance after EP procedures; leaves open causal mechanisms and need for prospective confirmation.
AIMS: Iatrogenic cardiac tamponades are a rare but dreaded complication of invasive electrophysiology procedures (EPs). Their long-term impact on clinical outcomes is unknown. This study analysed the risk of death or serious cardiovascular events in patients suffering from EP-related cardiac tamponade requiring pericardiocentesis during long-term follow-up. METHODS AND RESULTS: Out of 19 997 invasive EPs at the Karolinska University Hospital between January 1998 and September 2018, all patients with EP-related periprocedural cardiac tamponade were identified (n = 60) and matched (1:3 ratio) to a control group (n = 180). After a follow-up of 5 years, the composite primary endpoint - death from any cause, acute myocardial infarction, transitory ischaemic attack (TIA)/stroke, and hospitalization for heart failure - occurred in significantly more patients in the tamponade than in the control group [12 patients (20.0%) vs. 19 patients (10.6%); hazard ratio (HR) 2.53 (95% confidence interval, CI 1.15-5.58); P = 0.021]. This was mainly driven by a higher incidence of TIA/stroke in the tamponade than in the control group [HR 3.75 (95% CI 1.01-13.97); P = 0.049]. Death from any cause, acute myocardial infarction, and hospitalization for heart failure did not show a significant difference between the groups. Hospitalization for pericarditis occurred in significantly more patients in the tamponade than in the control group [HR 36.0 (95% CI 4.68-276.86); P = 0.001]. CONCLUSION: Patients with EP-related cardiac tamponade are at higher risk for cerebrovascular events during the first 2 weeks and hospitalization for pericarditis during the first months after index procedure. Despite the increased risk for early complications tamponade patients have a good long-term prognosis without increased risk for mortality or other serious cardiovascular events.
No takes yet. Share an insight, caveat, or question.
Olshausen et al. (2020) conducted a cohort in Invasive electrophysiology procedure-related cardiac tamponade (n=240). EP-related cardiac tamponade vs. Matched control group without tamponade was evaluated on Composite of death from any cause, acute myocardial infarction, transitory ischaemic attack (TIA)/stroke, and hospitalization for heart failure (HR 2.53, 95% CI 1.15-5.58, p=0.021). EP-related cardiac tamponade was associated with a higher 5-year risk of death, MI, TIA/stroke, or heart failure hospitalization compared to matched controls (20.0% vs 10.6%; HR 2.53; P=0.021).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: